Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01880034|
Recruitment Status : Completed
First Posted : June 18, 2013
Last Update Posted : May 12, 2017
Significant data exists to suggest that lipid emulsion administration in the setting of local anesthetic toxicity has the potential to be life-saving. Unfortunately, a variety of potential barriers exist to routine lipid emulsion administration for those performing regional anesthesia including drug availability, drug cost and drug location. Inadequate training or lack of established protocols also have the potential to negatively impact patient outcomes. A previous study by Toledo et al (Availability of lipid emulsion in United States obstetric units. Anesth Analg 2013;116:406-408.) evaluated lipid emulsion availability on obstetric units and found that it was nearly universally available.
The Accreditation Council for Graduate Medical Education (ACGME) publishes a list of contact information for each anesthesia institution that engages in resident training. Investigators will contact these institutions by phone or email to obtain contact information for their regional anesthesia program director. In the absence of a program director, investigators will send a survey and consent information via email to the faculty physician most involved in regional anesthesia. Survey completion instructions (survey itself to be completed on Qualtrics Survey Hosting Service) and copy of the study consent form will be attached to the initial contact email. The study consent form will contain a description of the study itself. Survey participants will be allowed time to complete their survey in private at their discretion. Non-responders will receive two follow-up emails at one month intervals.
|Condition or disease||Intervention/treatment|
|Local Anesthetic Systemic Toxicity||Other: Lipid Emulsion Survey|
|Study Type :||Observational|
|Actual Enrollment :||18 participants|
|Official Title:||Availability of Lipid Emulsion to Regional Anesthesia Programs at US Academic Anesthesia Departments|
|Study Start Date :||June 2013|
|Actual Primary Completion Date :||December 2014|
|Actual Study Completion Date :||December 2014|
Regional Anesthesia Section Heads
This group will consist of Regional Anesthesia Section Heads at anesthesia residency training programs.
Other: Lipid Emulsion Survey
- Is lipid emulsion available at all locations where regional anesthesia is practiced in your institution? [ Time Frame: Two months ]
Survey options include
- Yes, lipid emulsion is available in the room where regional anesthesia is performed.
- Yes, lipid emulsion is available in a near-by pharmacy
- Yes, lipid emulsion is available in a central pharmacy
- No, lipid emulsion is not available in all locations where regional anesthesia is performed
- If lipid emulsion is available to those practicing regional anesthesia at your institution, how long would it take to obtain it? [ Time Frame: Two Months. ]
Possible responses include:
- Lipid emulsion is not available at our institution.
- Less than 10 minutes
- 10-30 minutes
- More than 30 minutes
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01880034
|United States, Wisconsin|
|University of Wisconsin School of Medicine and Public Health|
|Madison, Wisconsin, United States, 53792|